Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Paradigm Medical Industries, a medical device company, has signed a distribution agreement with Costruzione Strumenti Oftalmici or CSO, an Italian manufacturer of ophthalmic instruments, whereby Paradigm will represent exclusively one of CSO's products, Retimax, the next generation for standard ocular electrophysiology, in the US market.
Subscribe to our email newsletter
The Retimax reportedly performs innovative tests for the early screening and follow-up of important pathologies like Glaucoma, age related Maculopaty, vascular retinal degeneration and other optic nerve diseases. Paradigm will also distribute additional ophthalmic products in the international and domestic markets.
Stephen Davis, president of Paradigm Medicals, said: “This new partnership will create many new opportunities for both organizations. We are excited to be chosen as CSO’s exclusive distributor of their Retimax product in the domestic markets, we expect to do very well in the US. This new partnership will also open up new doors for future cooperative product development.”